Galapagos NV ROCE Ratio 2011-2026 | GLPG

Annual ROCE Ratio Galapagos NV

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-3.51	6.71	-3.86	-8.06	5.51	-24.17	-17.11	-5.7	-1.66	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
6.71	-24.17	-5.76

Quarterly ROCE Ratio Galapagos NV

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-0.96	-1.93	-1.93	-0.96	-2.65	-3.37	-3.37	-1.68	-5.48	-7.59	-7.59	-3.79	-7.32	-7.05	-7.05	-3.52	-5.55	-4.06	-4.06	-2.03	-2.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-0.96	-7.59	-4.0

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Adagene ADAG	-46.22	$ 2.62	28.82 %	$ 147 M	China
GlaxoSmithKline plc GSK	13.35	$ 48.98	0.68 %	$ 173 B	Britain
Acorda Therapeutics ACOR	167.74	-	-24.86 %	$ 820 K	USA
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
Alterity Therapeutics Limited ATHE	-104.38	$ 3.51	7.34 %	$ 8.45 B	Australia
AgeX Therapeutics AGE	-180.78	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Grifols, S.A. GRFS	7.15	$ 9.25	1.49 %	$ 6.83 B	Spain
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	-40.28	-	-	$ 1.01 B	USA
Amphastar Pharmaceuticals AMPH	28.05	$ 25.92	-0.86 %	$ 1.26 B	USA
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Ultragenyx Pharmaceutical RARE	-209.94	$ 24.45	4.49 %	$ 2.21 B	USA
Aptose Biosciences APTO	-46.69	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	-664.7	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	-225.02	-	-	$ 269 M	USA
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
AVROBIO AVRO	10.76	-	1083.1 %	$ 745 M	USA
BioLineRx Ltd. BLRX	-104.07	$ 3.1	4.49 %	$ 908 M	Israel
Applied Molecular Transport AMTI	-209.11	-	-	$ 10.1 M	USA
BioNTech SE BNTX	-4.81	$ 116.27	-1.86 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Ascendis Pharma A/S ASND	-45.89	$ 235.41	2.95 %	$ 5 B	Danmark
BioXcel Therapeutics BTAI	72.23	$ 1.84	1.66 %	$ 4.66 M	USA
Burford Capital Limited BUR	14.24	$ 9.74	-1.37 %	$ 1.55 B	Britain
ARCA biopharma ABIO	-23.06	-	1052.0 %	$ 415 M	USA
Aytu BioScience AYTU	-12.81	$ 2.66	-1.85 %	$ 16.7 M	USA
Acasti Pharma ACST	-25.04	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	8.53	$ 67.49	-3.02 %	$ 9.03 B	USA
Brickell Biotech BBI	-64.05	-	-5.38 %	$ 6.06 M	USA
Can-Fite BioPharma Ltd. CANF	-115.03	$ 4.51	8.41 %	$ 9.81 B	Israel
BeiGene, Ltd. BGNE	-15.33	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	-353.66	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	-28.92	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	-70.32	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
Acer Therapeutics ACER	146.85	-	2.71 %	$ 14 M	USA
Bellicum Pharmaceuticals BLCM	-1339.01	-	-9.72 %	$ 5.89 M	USA
Alpine Immune Sciences ALPN	-32.41	-	-	$ 2.17 B	USA
AlloVir ALVR	-57.76	-	4.14 %	$ 49.1 M	USA
Coherus BioSciences CHRS	105.05	$ 2.04	28.3 %	$ 192 M	USA
Ampio Pharmaceuticals AMPE	-75.24	-	-11.43 %	$ 502 K	USA
Biogen BIIB	31.45	$ 171.89	-1.1 %	$ 25 B	USA
Bio-Path Holdings BPTH	-3592.52	-	-	$ 100 K	USA
BioVie BIVI	-95.03	$ 1.2	-3.7 %	$ 1.77 M	USA